Country | Sample size (% exposed) | Unmet need treatment effects† (95% CI) | Unmet need treatment effects† (95% CI) | Unmet need treatment effects† (95% CI) |
---|---|---|---|---|
(1) Null model | (2) Individual-level covariates | (3) Individual and country-level covariates | ||
Pooled | 367,208 | − 5.7*** | − 6.0*** | − 6.2*** |
(33.6%) | (− 8.4, − 3.0) | (− 8.8, − 3.2) | (− 9.2, − 3.2) | |
Ethiopia | 176,082 | − 11.6*** | − 13.4*** | − 14.9*** |
(8.6%) | (− 13.7, − 9.6) | (− 15.3, − 11.4) | (− 17.3, − 12.4) | |
Ghana | 162,998 | − 0.75 | − 0.25 | 11.04 |
(2.3%) | (− 6.1, 4.6) | (− 6.1, 5.6) | (− 6.3, 28.4) | |
Lesotho | 165,219 | − 10.6*** | − 10.0*** | − 3.4 |
(1.7%) | (− 13.1, − 8.2) | (− 12.5, − 7.4) | (− 13.5, 6.7) | |
Madagascar | 177,097 | 0.17 | 0.17 | 0.4 |
(9.7%) | (− 2.4, 2.8) | (− 2.6, 2.9) | (− 1.2, 1.9) | |
Malawi | 190,420 | − 2.8*** | − 3.7*** | − 8.7*** |
(12.6%) | (− 4.7, − 0.9) | (− 5.9, − 1.4) | (− 14.3, − 3.0) | |
Namibia | 162,143 | − 10.1*** | − 10.3*** | − 1.4 |
(2.2%) | (− 11.4, − 8.9) | (− 11.9, − 8.7) | (− 15.2, 12.3) | |
Rwanda | 177,739 | − 11.6*** | − 12.2*** | − 12.4*** |
(9.0%) | (− 12.8, − 10.4) | (− 13.5, − 10.9) | (− 13.1, − 11.8) | |
Zambia | 176,250 | − 3.7*** | − 3.8*** | − 6.5*** |
(7.8%) | (− 4.2, − 3.2) | (− 4.5, − 3.1) | (− 9.5, − 3.6) | |
Zimbabwe | 169,750 | 1.3 | 0.4 | − 4.8 |
(5.2%) | (− 1.5, 4.1) | (− 2.5, 3.2) | (− 16.4, 6.8) |